Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Summary

The purpose of this study was to allow the continuation of everolimus treatment in patients who have completed the core study (NCT00170885) and to collect long-term safety, tolerability, and efficacy data in a group of patients treated with the upper everolimus target levels plus very low dose cyclosporin in comparison with the standard everolimus target levels plus low dose cyclosporin in patients with renal transplantation.

Timeline

Start

2006-05

Primary completion

2009-02

Completion

2009-02

Drugs

Indications